Laboratory diagnosis of viral hepatitis in China: the present and the future

Y M Wen1

  • 1Department of Molecular Virology, Medical Center of Fudan University, Shanghai, China. ymwen@shmu.edu.cn

Insights

Viral hepatitis, including types A, B, C, D, and E, is common in China. Current diagnostic methods primarily rely on serological tests, with nucleic acid assays reserved for research and therapy evaluation.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Public Health in China

Background:

  • Viral hepatitis represents a significant public health concern in China.
  • All five major types of viral hepatitis (A, B, C, D, E) are prevalent.
  • High incidence rates are observed across the Chinese population for these viral infections.

Purpose of the Study:

  • To summarize the current landscape of viral hepatitis diagnosis in China.
  • To highlight the roles of serological and nucleic acid-based assays.
  • To inform epidemiological and therapeutic strategies.

Main Methods:

  • Review of diagnostic methodologies for viral hepatitis.
  • Analysis of the application of serological tests.
  • Assessment of the current use of nucleic acid-based assays.

Main Results:

  • Serological tests are the primary diagnostic tool for hepatitis A, B, C, and E in clinical and epidemiological settings.
  • These tests are also crucial for evaluating vaccine efficacy.
  • Nucleic acid-based assays are currently limited to research purposes and the assessment of antiviral and immunotherapies.

Conclusions:

  • Serological testing remains the cornerstone for routine viral hepatitis diagnosis and vaccine efficacy studies in China.
  • The utilization of nucleic acid assays is specialized, focusing on advanced research and treatment monitoring.
  • Further integration of advanced molecular diagnostics may be warranted for broader clinical application.